Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00902343 · ClinicalTrials.gov registry record · Phase 3
Controlled Trial Comparing Nomogram-based Versus Standard Allocation of Acute Normovolemic Hemodilution (ANH) During Hepatic Resection
A Phase 3 study, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- Phase 3
- Development phase
- 149
- Enrollment target
NCT00902343: Completed Phase 3 study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT00902343 is a Phase 3 study that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 149 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00902343, a Phase 3 study, has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 149 participants
- Enrollment target
Study Summary
The purpose of this study is to learn the best method of assigning patients to receive "acute normovolemic hemodilution" during liver surgery.
Interventions
- PROCEDURE nomogram-based selection for acute normovolemic hemodilution
- PROCEDURE standard selection for ANH based on a planned resection of 3 or more segments
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 149 participants |
| Start Date | 2009-05 |
| Est. Completion | 2015-04 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00902343
The ClinicalTrials.gov registry entry for NCT00902343 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 149 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which nomogram-based selection for acute normovolemic hemodilution is the first listed.
NCT00902343 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00902343 about?
NCT00902343 is a clinical study titled "Controlled Trial Comparing Nomogram-based Versus Standard Allocation of Acute Normovolemic Hemodilution (ANH) During Hepatic Resection". The purpose of this study is to learn the best method of assigning patients to receive "acute normovolemic hemodilution" during liver surgery.
What is the current status of trial NCT00902343?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 149 participants. The study started on 2009-05. Estimated completion is 2015-04.
What interventions are being tested in trial NCT00902343?
The interventions under investigation include: nomogram-based selection for acute normovolemic hemodilution (PROCEDURE), standard selection for ANH based on a planned resection of 3 or more segments (PROCEDURE).
Who is sponsoring clinical trial NCT00902343?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.